Search Results

There are 4496 results for: content related to: Early Treatment of Migraine With Rizatriptan: A Placebo-Controlled Study

  1. Sumatriptan (oral route of administration) for acute migraine attacks in adults

    Intervention Review

    The Cochrane Library

    Christopher J Derry, Sheena Derry and R Andrew Moore

    Published Online : 15 FEB 2012, DOI: 10.1002/14651858.CD008615.pub2

  2. You have free access to this content
    Influence of β-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol

    British Journal of Clinical Pharmacology

    Volume 52, Issue 1, July 2001, Pages: 69–76, Michael R. Goldberg, David Sciberras, Marina De Smet, Richard Lowry, Lisa Tomasko, Yih Lee, Timothy V. Olah, Jamie Zhao, Kamlesh P. Vyas, Rita Halpin, Prasad H. Kari and Ian James

    Article first published online : 20 DEC 2001, DOI: 10.1046/j.0306-5251.2001.01417.x

  3. Pharmacokinetic Profile of Rizatriptan 10-mg Tablet and 10-mg Orally Disintegrating Tablet Administered With or Without Water in Healthy Subjects: An Open-Label, Randomized, Single-Dose, 3-Period Crossover Study

    The Journal of Clinical Pharmacology

    Volume 46, Issue 2, February 2006, Pages: 172–178, Dr Suzanne K. Swan, Dr Harry Alcorn Jr, Mr Anthony Rodgers, Dr Carolyn M. Hustad, Ms Karen E. Ramsey, Ms Susan Woll and Dr Franck Skobieranda

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270005284194

  4. Pharmacokinetics and Tolerability of Rizatriptan in Pediatric Migraineurs in a Randomized Study

    Headache: The Journal of Head and Face Pain

    Volume 52, Issue 4, April 2012, Pages: 625–635, Iain P. Fraser, Lingling Han, Tae H. Han, Chi-Chung Li, David Hreniuk, S. Aubrey Stoch, John A. Wagner, Steven Linder and Paul Winner

    Article first published online : 30 JAN 2012, DOI: 10.1111/j.1526-4610.2011.02069.x

  5. Ten Years of Rizatriptan: From Development to Clinical Science and Future Directions

    Headache: The Journal of Head and Face Pain

    Volume 49, Issue s1, February 2009, Pages: S3–S20, Richard J. Hargreaves, Chris R. Lines, Alan M. Rapoport, Tony W. Ho and Fred D. Sheftell

    Article first published online : 21 JAN 2009, DOI: 10.1111/j.1526-4610.2008.01335.x

  6. Rizatriptan in acute treatment of migraine: update on new comparative data

    Cephalalgia

    Volume 20, Issue s1, November 2000, Pages: 10–15, PJ Goadsby

    Article first published online : 4 JAN 2002, DOI: 10.1046/j.1468-2982.2000.020s1010.x

  7. Elimination of Migraine-Associated Nausea in Patients Treated with Rizatriptan Orally Disintegrating Tablet (ODT): A Randomized, Double-Blind, Placebo-Controlled Study

    Headache: The Journal of Head and Face Pain

    Volume 48, Issue 3, March 2008, Pages: 368–377, Fred Freitag, Frederick R. Taylor, Mohammed A. Hamid, Anthony Rodgers, Carolyn M. Hustad, Karen E. Ramsey and Franck Skobieranda

    Article first published online : 28 NOV 2007, DOI: 10.1111/j.1526-4610.2007.00954.x

  8. Crossover Comparison of Rizatriptan 5 mg and 10 mg Versus Sumatriptan 25 mg and 50 mg in Migraine

    Headache: The Journal of Head and Face Pain

    Volume 38, Issue 10, November 1998, Pages: 737–747, Jerome Goldstein, Robert Ryan, Kaihong Jiang, Albert Getson, Barbara Norman, Gilbert A. Block, Christopher Lines and Rizatriptan Protocol 046 Study Group

    Article first published online : 31 MAY 2002, DOI: 10.1046/j.1526-4610.1998.3810737.x

  9. Efficacy and Safety of Rizatriptan Versus Standard Care During Long-term Treatment for Migraine

    Headache: The Journal of Head and Face Pain

    Volume 38, Issue 10, November 1998, Pages: 764–771, Gilbert A. Block, Jerome Goldstein, Adam Polis, Scott A. Reines, Mary E. Smith and Rizatriptan Multicenter Study Groups

    Article first published online : 31 MAY 2002, DOI: 10.1046/j.1526-4610.1998.3810764.x

  10. Rizatriptan, a Novel 5-HT1B/1D Agonist for Migraine: Single- and Multiple-Dose Tolerability and Pharmacokinetics in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 40, Issue 1, January 2000, Pages: 74–83, Michael R. Goldberg, Yih Lee, Kamlesh P. Vyas, Donald E. Slaughter, Deborah Panebianco, Susan J. Ermlich, Craig R. Shadle, Mary Jo Brucker, Debra A. McLoughlin and Timothy V. Olah

    Article first published online : 19 MAR 2013, DOI: 10.1177/009127000004000110

  11. You have full text access to this OnlineOpen article
    Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans

    International Journal of Clinical Practice

    Volume 61, Issue 7, July 2007, Pages: 1091–1111, D. S. Ng-Mak, X. H. Hu, Y. Chen, L. Ma and G. Solomon

    Article first published online : 30 MAY 2007, DOI: 10.1111/j.1742-1241.2007.01400.x

  12. Clinical–biochemical correlates of migraine attacks in rizatriptan responders and non-responders

    Cephalalgia

    Volume 26, Issue 3, March 2006, Pages: 257–265, P Sarchielli, LA Pini, G Zanchin, A Alberti, F Maggioni, C Rossi, A Floridi and P Calabresi

    Article first published online : 24 AUG 2005, DOI: 10.1111/j.1468-2982.2005.01016.x

  13. Efficacy and safety of rizatriptan wafer for the acute treatment of migraine

    Cephalalgia

    Volume 19, Issue 5, June 1999, Pages: 525–530, SP Ahrens, MV Farmer, DL Williams, E Willoughby, K Jiang, GA Block, WH Visser and Rizatriptan Wafer Protocol 049 Study Group

    Article first published online : 22 JUL 2009, DOI: 10.1046/j.1468-2982.1999.019005525.x

  14. Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials

    Cephalalgia

    Volume 21, Issue 2, March 2001, Pages: 129–136, Md Ferrari, E Loder, Ka McCarroll and Cr Lines

    Article first published online : 20 DEC 2001, DOI: 10.1046/j.1468-2982.2001.00169.x

  15. Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine

    Cephalalgia

    Volume 26, Issue 3, March 2006, Pages: 246–256, MJA Láinez, S Evers, E Kinge, G Allais, C Allen, NA Rao, R Massaad and K Lis

    Article first published online : 12 JAN 2006, DOI: 10.1111/j.1468-2982.2006.00991.x

  16. A Double-Blind, Placebo-Controlled Evaluation of the Effect of Oral Doses of Rizatriptan 10 mg on Oral Contraceptive Pharmacokinetics in Healthy Female Volunteers

    The Journal of Clinical Pharmacology

    Volume 40, Issue 3, March 2000, Pages: 309–315, Craig R. Shadle, Guanghan Liu and Michael R. Goldberg

    Article first published online : 8 MAR 2013, DOI: 10.1177/00912700022008865

  17. Rizatriptan 5 mg for the Acute Treatment of Migraine in Adolescents: Results From a Double-Blind, Single-Attack Study and Two Open-Label, Multiple-Attack Studies

    Headache: The Journal of Head and Face Pain

    Volume 44, Issue 9, October 2004, Pages: 891–899, W. Hester Visser, Paul Winner, Kim Strohmaier, Meghan Klipfel, Yahong Peng, Kathleen McCarroll, Roger Cady, Donald Lewis, Robert Nett and on behalf of the Rizatriptan Protocol 059 and 061 Study Groups

    Article first published online : 22 SEP 2004, DOI: 10.1111/j.1526-4610.2004.04171.x

  18. Almotriptan Versus Rizatriptan in Patients With Migraine in Spain

    Headache: The Journal of Head and Face Pain

    Volume 43, Issue 7, July 2003, Pages: 734–741, Rogelio Leira, Elena Dualde, Horacio Del Barrio, Manuel Machuca, Arturo López-Gil and Spanish Group for the Study of Triptan Consumption in Community Pharmacies

    Article first published online : 25 JUL 2003, DOI: 10.1046/j.1526-4610.2003.03131.x

  19. Effect of Rizatriptan and Other Triptans on the Nausea Symptom of Migraine: A Post Hoc Analysis

    Headache: The Journal of Head and Face Pain

    Volume 41, Issue 8, September 2001, Pages: 754–763, Richard B. Lipton, Julio Pascual, Peter J. Goadsby, Helene Massiou, Kathleen A. McCarroll, Kristel Vandormael, Kaihong Jiang and Christopher R. Lines

    Article first published online : 9 OCT 2008, DOI: 10.1046/j.1526-4610.2001.01139.x

  20. You have free access to this content
    The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 48, Issue 2, August 1999, Pages: 190–196, A. D. Van Haarst, J. M. A. Van Gerven, A. F. Cohen, M. De Smet, A. Sterrett, K. L. Birk, A. L. Fisher, M. E. De Puy, M. R. Goldberg and D. G. Musson

    Article first published online : 6 MAY 2005, DOI: 10.1046/j.1365-2125.1999.00011.x